|
|
Datum upisa
|
| 4659 |
Physicochemical stability of cloxacillin solutions in polypropylene syringes at
125 mg/mL in 0.9% sodium chloride and dextrose 5% in water; EAHP Virtual Congress 2021 |
27/01/2022 |
| 4652 |
Nivolumab (Opdivo®) - Summary of Product Characteristics Bristol Myers Squibb Pharmaceuticals |
22/01/2022 |
| 4650 |
Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma |
12/01/2022 |
| 4640 |
Stability of Ampicillin in Normal Saline Following Refrigerated Storage and 24-Hour Pump Recirculation. Hosp Pharm |
08/11/2021 |
| 4641 |
Stability of high concentrated triple intrathecal therapy for pediatrics and mitigation strategies. Eur J Pharm Sci |
08/11/2021 |
| 4638 |
Stability of Extemporaneously Compounded Suspensions of Trimethoprim and Sulfamethoxazole in Amber Plastic Bottles and Amber Plastic Syringes. Can J Hosp Pharm |
03/11/2021 |
| 4639 |
Stability of N-Acetylcysteine 60 mg/mL in Extemporaneously Compounded Injectable Solutions. Can J Hosp Pharm |
03/11/2021 |
| 4637 |
Evaluation of physicochemical and microbiological stability of liquid preparation from tizanidine hydrochloride tablets - a Hospital concern. Braz J Pharm Sci |
26/10/2021 |
| 4635 |
Physicochemical stability of human insulin 1 I.U./mL infusion solution in 50 mL polypropylene syringes. Pharmaceutical Technology in Hospital Pharmacy |
04/10/2021 |
| 4629 |
Pemetrexed Sandoz - Summary of Product Characteristics (SmPc) |
27/09/2021 |
| 4628 |
Development and Validation of a New Storage Procedure to Extend the In-Use Stability of Azacitidine in Pharmaceutical Formulations. Pharmaceuticals |
24/09/2021 |
| 4619 |
Stability Study for Clindamycin 9.52mg/mL in 5.0% w/v Glucose 50mL Infusion Bags. Quality Control North West, Stockport NHS Foundati |
15/09/2021 |
| 4620 |
Stability Study for Piperacillin/Tazobactam 56.9 mg/mL in Sodium Chloride 0.9% w/v in 50mL Infusion Bags. Quality Control North West, Stockport NHS Foundati |
15/09/2021 |
| 4621 |
Stability Study for Piperacillin/Tazobactam 56.9 mg/mL in Glucose 5.0% w/v in 50mL Infusion Bags. Quality Control North West, Stockport NHS Foundati |
15/09/2021 |
| 4622 |
Stability Study for Clindamycin 9.52mg/mL in 0.9% w/v Sodium Chloride 50mL Infusion Bags. Quality Control North West, Stockport NHS Foundati |
15/09/2021 |
| 4617 |
Isatuximab - SARCLISA 20mg/mL concentrate for solution for infusion - Summary of Product Characteristics - updated 16 August 2021 Sanofi Genzyme |
10/09/2021 |
| 4618 |
Physicochemical stability of cefiderocol, a novel siderophore cephalosporin, in syringes at 62.5 mg/mL for continuous administration in intensive care units. EJHP |
10/09/2021 |
| 4612 |
Estabilidad de la solución de gentamicina y heparina para sellado de catéter. OFIL |
26/08/2021 |
| 4608 |
Durvalumab (Imfinzi - Summery of Product Characteristics, updated August 2021) Astra Zeneca |
19/08/2021 |
| 4607 |
Stability of Compounded Clozapine 25 mg/mL and 50 mg/mL Suspensions in Plastic Bottles. Can J Hosp Pharm |
13/08/2021 |
| 4606 |
Study on the Optimal Conditions for Long-term Storage of Melatonin Powder as an In-hospital Preparation. Int J Pharm Compound |
10/08/2021 |
| 4605 |
Impact of physical incompatibility on drug mass flow rates: example of furosemide-midazolam incompatibility. Ann Allergy |
09/08/2021 |
| 4602 |
Physical and Chemical Stability of Dexamethasone Sodium Phosphate in Intravenous Admixtures Used to Prevent Chemotherapy-Induced Nausea and Vomiting. Hosp Pharm |
06/08/2021 |
| 4603 |
Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration. Hosp Pharm |
06/08/2021 |
| 4600 |
Physicochemical stability of lurbinectedin reconstituted at 500 µg/mL and diluted at 15, 30, and 70 µg/mL in 0.9% sodium chloride and 5% dextrose. EJOP |
04/08/2021 |
| 4596 |
Stability of 5% vancomycin ophthalmic solution prepared using balanced salt solution after freezing for 90 days. Am J Health-Syst Pharm |
02/08/2021 |
| 4592 |
The Role of Non-Enzymatic Degradation of Meropenem—Insights from the Bottle to the Body. Antibiotics |
30/06/2021 |
| 4589 |
Pemetrexed Mylan - Résumé des caractéristiques du produit Mylan |
18/06/2021 |
| 4587 |
Stability-indicating LC-MS Method for Determination of Stability of Extemporaneously Compounded Buprenorphine Oral Syringes for Neonatal Abstinence Syndrome. J Pediatr Pharmacol Ther |
09/06/2021 |
| 4584 |
Long-term stability of 10 mg/mL dobutamine injectable solutions in 5% dextrose and normal saline solution stored in polypropylene syringes and cyclic-oleofin- copolymer vials. EJHP |
26/05/2021 |
